MedTrace Logo

Panadol Osteo Pharmaceuticals Benefit Scheme (PBS) Claims Cohort Study

NCT02262702 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-01-25

No results posted yet for this study

Summary

The aim of this observational study is to compare the use of an extended release paracetamol formulation with standard paracetamol in a cohort of Australian concessional patients with osteoarthritis (OA), to assess differences in prescribing patterns and patient compliance.

Conditions

Interventions

DRUG

Paracetamol 665 mg

Paracetamol 665 mg tablet

DRUG

Paracetamol 500 mg

Paracetamol 500 mg tablet

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-01-31
Completion
2013-01-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02262702 on ClinicalTrials.gov